ncs-import
Friday, October 21, 2016
PDL BioPharma Inc. of Incline Village, the owner of a portfolio of royalty interest on biopharmaceutical patents, says it expects third quarter revenue of $165 million. This compares with $100.2 million in the third quarter of last year.
Use the comment form below to begin a discussion about this content.
Username
Password Forgot?
Sign in
Password
Confirm password
Email
Sign up
Northern Nevada Business Weekly
May 2, 2024 7:05 a.m.
May 2, 2024 7 a.m.
May 2, 2024 6:30 a.m.
May 2, 2024 6:15 a.m.
May 1, 2024 7 a.m.
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment